New York State Common Retirement Fund Rocket Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 23,017 shares of RCKT stock, worth $274,362. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,017
Previous 27,617
16.66%
Holding current value
$274,362
Previous $595,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$211 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$134 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$73.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$66 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$53.6 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $902M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...